A Multicenter Partially-Masked Randomized Controlled Study of Maximal Medical Therapy vs. Maximal Medical Therapy plus Optic Nerve Sheath Fenestration vs. Initial Medical Therapy plus Stereotactic Ventriculoperitoneal Cerebrospinal Fluid Shunting in Su

Brief description of study

When vision loss from IIH is moderate to severe, several medications and surgical treatments can be used. Although each of these treatments can be effective, doctors are still not sure which treatments work best. The purpose of this study is to find out which treatment works best to reduce or reverse visual loss in people with Idiopathic Intracranial Hypertension (IIH). The purpose of this study is to find out how different treatments work to reduce or reverse visual loss in people who have a condition where the pressure inside the skull increases for no known reason. This is called idiopathic intracranial hypertension (IIH). When vision loss from IIH is moderate to severe, several medications and surgical treatments can be used. Although each of these treatments can be effective, doctors are still not sure which treatments work best. This study aims to find out which treatment works best to restore vision for people with IIH.


Clinical Study Identifier: s18-00336
ClinicalTrials.gov Identifier: NCTs18-00336


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.